Intersect ENT (XENT) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts XENT Hot Sheet
Join SI Premium – FREE
Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.2 million.
For earnings history and earnings-related data on Intersect ENT (XENT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Workhorse Group (WKHS) Misses Q2 EPS by 77c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
